Indeed, the initial designation of these compounds to BRCA1/BRCA2-mutated cancers already stemmed from the discovery of the synthetic lethal relationship between PARP1/PARP2 inhibition and faulty HR machinery40,41. This evidence concerns the gene PARP1 and cancer.